Research output per year
Research output per year
Accepting PhD Students
PhD projects
Anti-cancer compounds
Molecules against neurodegenerative diseases
Anti-microbial chelators
Therapeutic Metal chelators
Willing to speak to media
Metal chelators as therapeutic compounds, in particular in cancer, neurodegenerative diseases and as biostatic agents against microorganisms.
We focus on the design of powerful Fe(III) chelators of the hydroxypyridinone family that have been demonstrated by us and others to have activity as:
anticancer drugs, interfering with the biochemical processes involving metals (metalloenzymes, oxidative stress)
drugs against neurodegenerative diseases, preventing oxidative damage to neurons
biostatic agents, reducing the rate of growth of microorganisms.
I am an organic chemist who is designing novel powerful metal chelators, with a focus on Fe(III) that can have therapeutic applications, in particular against cancer, neurodegenerative diseases (Parkinson's Disease, Alzheimer's Disease) and as biostatic agents against micro-organisms. My molecules are based on rationale design, trying to optimise metal chelator and other functions such as cell penetration, multiple mode of action, targeting.
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Teaching & Learning, PCAPL
11 Oct 2007 → 10 Oct 2008
Award Date: 10 Oct 2008
Chemistry, PhD
1 Sept 1993 → 30 Oct 1996
Award Date: 30 Oct 1996
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review